Astrana Health (ASTH) Projected to Post Quarterly Earnings on Thursday

Key Points

• Astrana Health (NASDAQ:ASTH) is set to release its Q2 2025 quarterly earnings on Thursday, August 7th, with analysts estimating earnings of $0.36 per share and revenues of $639.13 million.
net margin of 1.56% and a return on equity of 4.90%, with revenues up 53.4% year-over-year despite missing the EPS consensus estimate.
• The company's stock recently opened at $24.08, and institutional investors now hold 52.77% of the company’s shares, indicating strong interest from hedge funds and other investors.

Astrana Health (NASDAQ:ASTH - Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect Astrana Health to post earnings of $0.36 per share and revenue of $639.13 million for the quarter. Astrana Health has set its Q2 2025 guidance at EPS and its FY 2025 guidance at EPS.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The company had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The company's revenue for the quarter was up 53.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.31 EPS. On average, analysts expect Astrana Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astrana Health Stock Down 9.6%

Astrana Health stock traded down $2.29 during midday trading on Friday, hitting $21.57. 638,034 shares of the company were exchanged, compared to its average volume of 319,618. The company has a market cap of $1.21 billion, a PE ratio of 29.96, a price-to-earnings-growth ratio of 0.88 and a beta of 0.84. Astrana Health has a fifty-two week low of $21.43 and a fifty-two week high of $63.20. The company's fifty day moving average price is $24.65 and its 200-day moving average price is $29.66. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ASTH. Jones Financial Companies Lllp lifted its stake in Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company's stock worth $346,000 after purchasing an additional 10,913 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company's stock worth $799,000 after buying an additional 1,263 shares during the last quarter. AQR Capital Management LLC acquired a new position in shares of Astrana Health in the 1st quarter valued at about $933,000. Intech Investment Management LLC boosted its holdings in shares of Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company's stock valued at $1,383,000 after buying an additional 2,462 shares during the period. Finally, Royal Bank of Canada boosted its holdings in shares of Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company's stock valued at $8,640,000 after buying an additional 17,028 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.